Monika Håkerud
- Engineer
- +47 22 78 14 57
In the project "PCI of therapeutic cancer vaccines" we use the PCI technology in combination with vaccines based on mRNA, peptides and nanoparticles.
Publications 2021
Photochemical Internalization Enhanced Vaccination Is Safe, and Gives Promising Cellular Immune Responses to an HPV Peptide-Based Vaccine in a Phase I Clinical Study in Healthy Volunteers
Front Immunol, 11, 576756
DOI 10.3389/fimmu.2020.576756, PubMed 33488576
Publications 2018
Photochemical Internalization of Peptide Antigens Provides a Novel Strategy to Realize Therapeutic Cancer Vaccination
Front Immunol, 9, 650
DOI 10.3389/fimmu.2018.00650, PubMed 29670624
Publications 2017
Endosome Targeting meso-Tetraphenylchlorin-Chitosan Nanoconjugates for Photochemical Internalization
Biomacromolecules, 18 (4), 1108-1126
DOI 10.1021/acs.biomac.6b01670, PubMed 28245649
Publications 2016
Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes
Mol Pharm, 13 (2), 320-9
DOI 10.1021/acs.molpharmaceut.5b00394, PubMed 26704885
Publications 2015
Photosensitizer and Light Pave the Way for Cytosolic Targeting and Generation of Cytosolic CD8 T Cells Using PLGA Vaccine Particles
J Immunol, 195 (1), 166-73
DOI 10.4049/jimmunol.1500431, PubMed 26019274
Publications 2014
Photosensitisation facilitates cross-priming of adjuvant-free protein vaccines and stimulation of tumour-suppressing CD8 T cells
J Control Release, 198, 10-7
DOI 10.1016/j.jconrel.2014.11.032, PubMed 25482339
Publications 2013
Tetraphenylporphyrin tethered chitosan based carriers for photochemical transfection
J Med Chem, 56 (3), 807-19
DOI 10.1021/jm301270r, PubMed 23281854
Intradermal photosensitisation facilitates stimulation of MHC class-I restricted CD8 T-cell responses of co-administered antigen
J Control Release, 174, 143-50
DOI 10.1016/j.jconrel.2013.11.017, PubMed 24280261
Photochemical targeting of antigens to the cytosol for stimulation of MHC class-I-restricted T-cell responses
Eur J Pharm Biopharm, 85 (1), 34-41
DOI 10.1016/j.ejpb.2013.02.002, PubMed 23461859
Publications 2010
Syntheses and structure-activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel alpha7 neuronal nicotinic receptor (NNR) ligands
Bioorg Med Chem Lett, 20 (12), 3636-9
DOI 10.1016/j.bmcl.2010.04.105, PubMed 20472430
In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107
J Pharmacol Exp Ther, 334 (3), 863-74
DOI 10.1124/jpet.110.167072, PubMed 20504915
Publications 2009
Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity alpha4beta2 subunit combination
Biochem Pharmacol, 78 (7), 844-51
DOI 10.1016/j.bcp.2009.06.024, PubMed 19555668
In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profile
J Pharmacol Exp Ther, 330 (1), 257-67
DOI 10.1124/jpet.109.151886, PubMed 19389923
Evaluation of alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators using the parallel oocyte electrophysiology test station
Assay Drug Dev Technol, 7 (4), 374-90
DOI 10.1089/adt.2009.0194, PubMed 19689206
Publications 2008
Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties
CNS Neurosci Ther, 14 (1), 65-82
DOI 10.1111/j.1527-3458.2008.00037.x, PubMed 18482100
Publications 2007
alpha7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues
Br J Pharmacol, 153 (5), 1054-61
DOI 10.1038/sj.bjp.0707649, PubMed 18157163
Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes
Mol Pharmacol, 72 (3), 715-24
DOI 10.1124/mol.107.035410, PubMed 17565004